The Endocrine Society’s 95th Annual Meeting & Expo to be held in San Francisco June 15–18 will showcase a century of scientifi c breakthroughs in four days. Set against the backdrop of San Francisco’s iconic Golden Gate Bridge, ENDO 2013 is the perfect venue for great feats in endocrinology.

Experts Abound

A number of notable experts will speak at ENDO 2013. The Clinical Investigator Award Lecture will be presented by Steven Kahn, M.B., Ch.B., who will highlight the roles of beta-cells in type 2 diabetes pathogenesis. In the Gerald D. Aurbach Award Lecture, Mitchell Lazar, M.D., Ph.D., will explore the infl uence of circadian epigenomic regulation on metabolism. Donald McDonnell, Ph.D., will examine the estrogen receptor’s mediation of bone and breast pathologies in the Roy O. Greep Award Lecture. Gary Hammer, M.D., Ph.D., will present the Edwin B. Astwood Award Lecture on the implications of adrenal stem cells for human disease.

The popular Master Clinician and Clinical Practice Guideline sessions will continue at ENDO 2013. Three Master Clinician sessions will provide in-depth examinations of complex adrenal, type 2 diabetes, and osteoporosis cases. Best treatment practices for diabetes and pregnancy, hypertriglyceridemia, and polycystic ovarian syndrome will be presented during three Clinical Practice Guideline sessions.

Endocrinology took the spotlight in 2012 with the awarding of the Nobel Prize in Chemistry to Brian Kobilka, M.D., and Robert Lefkowitz, M.D., for their studies on G protein–coupled receptors (GPCRs). To celebrate this achievement, ENDO 2013 is off ering a forum entitled “New Light on GPCRs,” which brings together global experts to present insights into GPCR structure/function and roles in metabolic regulation. For the “Year in GPCRs,” Graeme Milligan, Ph.D., F.R.S.E., will review developments in GPCR research made over the past year. The Clark T. Sawin Memorial Lecture, presented by Delbert A. Fisher awardee Jesse Roth, M.D., F.A.C.P., will delve into more than a century of advances in signaling.

A new and provocative feature is “Endocrinology and the News.” This special session will focus on interactions between scientists and the media with two researchers who have received increased scrutiny because of the controversial nature of their fi ndings. Tyrone Hayes, Ph.D., well-known for his work in endocrine disruptors, and Robert Lustig, M.D., a pediatric endocrinologist critical of high-fructose corn syrup, will discuss their experiences and strategies for media relations.

The new Featured Poster Presentations is one of the highlights atENDO 2013. These presentations will give select authors of high-scoring abstracts the opportunity to take the podium and present a preview of their posters. Those interested may submit their abstracts during the regular Call for Abstracts period that closes Jan. 30, 2013, at noon ET.

Downtown Excursions

The diversity of topics planned for ENDO 2013 complements the many communities and attractions within San Francisco’s 49 square miles. As the fi nancial and cultural heart of northern California, San Francisco off ers visitors world-class museums, music, and food among the varying neighborhoods. The Mission District is the city’s oldest neighborhood, founded in 1776, and has grown into a hotspot of galleries and ethnic restaurants. The Italian North Beach area is famous for its numerous jazz bars and gelato parlors, and San Francisco’s Chinatown remains the oldest and one of the largest such neighborhoods in the country. Top-notch dim sum restaurants speckle the streets, but cuisines of all kinds can be found within walking distance, or even by cable car. After a meal accompanied by a local craft beer, attendees may stroll across the Golden Gate Bridge or take a ferry across the foggy waters to Alcatraz. San Francisco’s accessible tourism sights provide plenty to do between ENDO 2013’s events.

More information for attendees can be found at www.endo-society.org/Endo2013. Conference registration opened on Dec. 5, 2012, for members, and will open Jan. 3, 2013, for non-members.

You may also like

  • Transgender Women May Be More Prone to Type 2 Diabetes than Cisgender Women

    Transgender women may be at higher risk for type 2 diabetes compared to cisgender women, but not to cisgender men, according to new research published in The Journal of Clinical Endocrinology & Metabolism. Nearly 1 million people identify as transgender in the U.S., and healthcare providers are encountering more transgender and gender-diverse patients in their practices. An important priority of transgender health research is to…

  • Heir Apparent: A Multi-Faceted Look at One of the Most Common Inherited Metabolic Disorders, Congenital Adrenal Hyperplasia

    Basic Researcher Nils Krone, MD, FRCPCH, Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK Clinical Researcher Richard J. Auchus, MD, PhD, Professor and Endocrinology Fellowship Program Director Division of Metabolism, Endocrinology, and Diabetes; Department of Internal Medicine, University of Michigan, Ann Arbor, Mich. Clinical Practitioner Nicole Reisch, MD, Head of CAH outpatient…

Find more in